Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Prime Venture Partners...

    Prime Venture Partners raises Rs 400 crore for investment in digitisation, healthcare

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-03-10T10:00:23+05:30  |  Updated On 10 March 2018 10:00 AM IST
    Prime Venture Partners raises Rs 400 crore for investment in digitisation, healthcare

    New Delhi: Prime Venture Partners, an early stage fund, announced the close of its third fund at Rs. 400 crore for investment in key sectors including Digital India, fintech/financial services, healthcare, education, logistics and global SaaS solutions.


    Previously, Prime had raised its first fund of USD 8 million in 2012, and a USD 46 million Fund 2 was raised in 2015. It was the first investor in ZipDial, a missed-call based startup that was acquired by Twitter in 2015, and Ezetap, a mobile payments company that has since raised about USD 50 million in follow-on capital and is a provider of enterprise-grade payment acceptance solutions in India.


    Prime is typically the first institutional investor in a startup. The firm follows a distinctive model of being highly selective and invests in only three to five companies per year, only after building deep conviction in entrepreneurs and their startups through a rapid yet thorough diligence process. A common theme among Prime portfolio companies is strong product and tech teams with unique insights and an ability to rapidly iterate.


    Portfolio companies work closely with all partners during the formative phase of the business, helping fine-tune all aspects of the company. The firm actively supports entrepreneurs with business and product strategy, refining operating metrics, hiring, partnerships, marketing, finance, all the way through raising subsequent capital.


    While most of Prime's portfolio companies are focussed on the booming Digital India opportunity,


    Prime also has several companies that target the US, Middle-East and other International markets, or that initially start in India and expand from India to other geographies. Most of these companies have gone on to raise strong follow-on rounds of investment from other leading Venture Capital firms in India, Silicon Valley and Asia.


    "Digital India is exploding; there has never been a more exciting time to be an entrepreneur in India. We are privileged to partner with amazing entrepreneurs who are building some of the most exciting emerging companies in India. We are also grateful for the fantastic support from our existing Limited Partners (LPs) and delighted to welcome some amazing new long-term LPs to our journey," said co-founder and managing partner of Prime Venture Partners, Sanjay Swamy.


    "The quality of technology entrepreneurship in India is growing non-linearly. It is driven by the fact that several employees of the first wave of tech startups have the maturity and exposure to solving problems at scale and are now turning entrepreneurs themselves," added Amit Somani, managing partner, Prime Venture Partners.

    Amit SomaniDigital IndiaEzetapHealthcareInvestmentPrime Venture PartnersSaaSSanjay SwamyVenture Capital firms
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok